+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Forecast 2024-2030- Product Image
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Forecast 2024-2030- Product Image
Sale

Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995357
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Autologous Stem Cell & Non-Stem Cell Based Therapies Market size was estimated at USD 7.17 billion in 2023, USD 8.22 billion in 2024, and is expected to grow at a CAGR of 14.78% to reach USD 18.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Autologous Stem Cell & Non-Stem Cell Based Therapies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market, highlighting leading vendors and their innovative profiles. These include Brainstorm Cell Therapeutics, Inc., Castle Creek Biosciences Inc., Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC, Gilead Sciences, Inc., HCA International Limited, Hemogenyx Pharmaceuticals PLC, Hemostemix Inc., Jasper Therapeutics, Inc., NOVADIP Biosciences S.A., Novartis AG, Opexa Therapeutics, Inc., Regeneus Ltd., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Autologous Stem Cell & Non-Stem Cell Based Therapies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Autologous Non-Stem Cells
    • Autologous Stem Cells
  • Indication
    • Cancer
    • Cardiovascular Disease
    • Neurodegenerative Disorders
    • Orthopedic Diseases
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Research Facilities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  3. What are the technology trends and regulatory frameworks in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  4. What is the market share of the leading vendors in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  5. Which modes and strategic moves are suitable for entering the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of cancer and diabetes among population
5.1.1.2. Increased demand to manage a large number of infectious diseases
5.1.1.3. Advantage of intensive therapy for older patients
5.1.2. Restraints
5.1.2.1. High costs associated with autologous stem cell & non-stem cell therapies
5.1.3. Opportunities
5.1.3.1. Rise in investment for extensive research and development
5.1.3.2. Advances in treating various diseases, neurodegenerative diseases and macular degeneration
5.1.4. Challenges
5.1.4.1. Risks and complications associated with the therapy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Type
6.1. Introduction
6.2. Autologous Non-Stem Cells
6.3. Autologous Stem Cells
7. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Indication
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Disease
7.4. Neurodegenerative Disorders
7.5. Orthopedic Diseases
8. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Research Facilities
9. Americas Autologous Stem Cell & Non-Stem Cell Based Therapies Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Autologous Stem Cell & Non-Stem Cell Based Therapies Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Autologous Stem Cell & Non-Stem Cell Based Therapies Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Brainstorm Cell Therapeutics, Inc.
13.1.2. Castle Creek Biosciences Inc.
13.1.3. Cytori Therapeutics Inc.
13.1.4. Dendreon Pharmaceuticals LLC
13.1.5. Gilead Sciences, Inc.
13.1.6. HCA International Limited
13.1.7. Hemogenyx Pharmaceuticals PLC
13.1.8. Hemostemix Inc.
13.1.9. Jasper Therapeutics, Inc.
13.1.10. NOVADIP Biosciences S.A.
13.1.11. Novartis AG
13.1.12. Opexa Therapeutics, Inc.
13.1.13. Regeneus Ltd.
13.1.14. Takeda Pharmaceutical Company Limited
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET RESEARCH PROCESS
FIGURE 2. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2023 VS 2030
FIGURE 3. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET DYNAMICS
FIGURE 7. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 9. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 14. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET LICENSE & PRICING

Companies Mentioned

  • Brainstorm Cell Therapeutics, Inc.
  • Castle Creek Biosciences Inc.
  • Cytori Therapeutics Inc.
  • Dendreon Pharmaceuticals LLC
  • Gilead Sciences, Inc.
  • HCA International Limited
  • Hemogenyx Pharmaceuticals PLC
  • Hemostemix Inc.
  • Jasper Therapeutics, Inc.
  • NOVADIP Biosciences S.A.
  • Novartis AG
  • Opexa Therapeutics, Inc.
  • Regeneus Ltd.
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.83 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Autologous Stem Cell & Non-Stem Cell Therapies Market by Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

Autologous Stem Cell & Non-Stem Cell Therapies Market by Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Forecast to 2029 - Product Image

Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Forecast to 2029

  • Report
  • 295 Pages
  • Global
From
Autologous Stem Cell and Non-Stem Cell Based Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Autologous Stem Cell and Non-Stem Cell Based Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type, Application, End User, and Region 2024-2032 - Product Image

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type, Application, End User, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
Autologous Stem Cell and Non-Stem Cell-based Therapies Global Market Report 2024 - Product Image

Autologous Stem Cell and Non-Stem Cell-based Therapies Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.